For the quarter ending 2025-12-31, GRCE has $68,488K in assets. $3,596K in debts. $18,672K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|
| Cash and cash equivalents | 18,672 | 16,862 | 20,005 | |
| Receivables | 20 | 20 | 20 | |
| Prepaid expenses | 519 | 416 | 500 | |
| Total current assets | 19,211 | 17,298 | 20,525 | |
| Equipment, net | 11 | 12 | 14 | |
| Intangible assets | 41,128 | 41,128 | 41,128 | |
| Goodwill | 8,138 | 8,138 | 8,138 | |
| Total assets | 68,488 | 66,576 | 69,805 | |
| Trade and other payables | 1,284 | 1,245 | 2,315 | |
| Total current liabilities | 1,284 | 1,245 | 2,315 | |
| Derivative warrant liabilities | 0 | 201 | 1,628 | |
| Deferred tax liability | 2,312 | 2,312 | 2,312 | |
| Total liabilities | 3,596 | 3,758 | 6,255 | |
| Common stock, 0.0001 par value per share 100,000,000 authorized 15,474,026 and 13,718,106 shares issued and outstanding as of december 31, 2025 and march 31, 2025, respectively | 1 | 1 | 1 | |
| Additional paid-in capital | 298,231 | 293,842 | 293,636 | |
| Accumulated other comprehensive loss | -6,038 | -6,038 | -6,038 | |
| Accumulated deficit | -227,302 | -224,987 | -224,049 | |
| Total stockholders' equity | 64,892 | 62,818 | 63,550 | |
| Total liabilities and stockholders equity | 68,488 | 66,576 | 69,805 | |
Grace Therapeutics, Inc. (GRCE)
Grace Therapeutics, Inc. (GRCE)